These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20567869)

  • 21. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR; Lemonovich TL
    Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of beta-lactam agents in the treatment of community-acquired pneumonia.
    Garau J
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):83-99. PubMed ID: 15696306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.
    Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A
    JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the combination and quinolone therapy in community acquired pneumonia].
    Kılıç Soylar Ö; Kılınç O; Ellidokuz H
    Tuberk Toraks; 2015 Sep; 63(3):165-9. PubMed ID: 26523897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Tokioka F; Yamazaki A; Washio Y; Irie H; Otake T
    J Infect Chemother; 2021 Oct; 27(10):1447-1453. PubMed ID: 34147355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease in drug resistance in pneumococcal community-acquired pneumonia.
    Obando I; Arroyo L; Sanchez-Tatay D
    Chest; 2007 Jul; 132(1):359; author reply 359-60. PubMed ID: 17625101
    [No Abstract]   [Full Text] [Related]  

  • 28. Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired Pneumonia.
    Kolditz M; Halank M; Höffken G
    Treat Respir Med; 2006; 5(6):371-83. PubMed ID: 17154666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.
    Waterer GW; Somes GW; Wunderink RG
    Arch Intern Med; 2001 Aug 13-27; 161(15):1837-42. PubMed ID: 11493124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis.
    Lee JH; Kim HJ; Kim YH
    J Korean Med Sci; 2017 Jan; 32(1):77-84. PubMed ID: 27914135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia.
    Weiss K; Tillotson GS
    Chest; 2005 Aug; 128(2):940-6. PubMed ID: 16100190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of initial antibiotic choice on mortality from pneumococcal pneumonia.
    Aspa J; Rajas O; Rodriguez de Castro F; Huertas MC; Borderías L; Cabello FJ; Tábara J; Hernández-Flix S; Martinez-Sanchis A; Torres A;
    Eur Respir J; 2006 May; 27(5):1010-9. PubMed ID: 16455824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia.
    Dwyer R; Ortqvist A; Aufwerber E; Henriques Normark B; Marrie TJ; Mufson MA; Torres A; Woodhead MA; Alenius M; Kalin M
    Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):518-21. PubMed ID: 16896822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumococcal urinary antigen test: diagnostic yield and impact on antibiotic treatment.
    Laijen W; Snijders D; Boersma WG
    Clin Respir J; 2017 Nov; 11(6):999-1005. PubMed ID: 26780500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae.
    File TM
    Clin Infect Dis; 2002 Mar; 34 Suppl 1():S17-26. PubMed ID: 11810607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.
    Fernández Guerrero ML; Ramos JM; Marrero J; Cuenca M; Fernández Roblas R; de Górgolas M
    Int J Infect Dis; 2003 Mar; 7(1):46-52. PubMed ID: 12718810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-course beta-lactam treatment for community-acquired pneumonia.
    Stralin K; Sjöberg L; Holmberg H
    Clin Infect Dis; 2004 Mar; 38(5):766-7. PubMed ID: 14986269
    [No Abstract]   [Full Text] [Related]  

  • 39. Does empirical therapy with a fluoroquinolone or the combination of a β-lactam plus a macrolide result in better outcomes for patients admitted to the general ward?
    Ruhe J; Mildvan D
    Infect Dis Clin North Am; 2013 Mar; 27(1):115-32. PubMed ID: 23398869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
    Vetter N; Cambronero-Hernandez E; Rohlf J; Simon S; Carides A; Oliveria T; Isaacs R;
    Clin Ther; 2002 Nov; 24(11):1770-85. PubMed ID: 12501873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.